Vasorelaxant effect of formononetin in the rat thoracic aorta and its mechanisms

Journal of Asian Natural Products Research

Volumn 14, Issue 1, 2012, Pages 46-54

  Zhao, Yan ^a,b   Chen, Bai Nian ^a   Wang, Shou Bao ^a   Wang, Shao Hua ^b   Du, Guan Hua ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b QINGDAO MUNICIPAL HOSPITAL   (China)

Author keywords

aorta; calcium; formononetin; nitric oxide; vasorelaxation

Indexed keywords

CALCIUM; CALCIUM CHANNEL; FORMONONETIN; GLIBENCLAMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; POTASSIUM CHANNEL; VASODILATOR AGENT;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MALE; NONHUMAN; SYNTHESIS; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASCULAR RING; VASODILATATION;

ANIMALS; AORTA, THORACIC; CALCIUM; CALCIUM CHANNELS; DOSE-RESPONSE RELATIONSHIP, DRUG; ISOFLAVONES; MOLECULAR STRUCTURE; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NOREPINEPHRINE; POTASSIUM CHANNELS; POTASSIUM CHLORIDE; RATS; VASODILATION; VASODILATOR AGENTS;

RATTUS;

EID: 84863181539     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020.2011.628939     Document Type: Article

References (25)

1. Ji, Z.N., Zhao, W.Y., Liao, G.R., Choi, R.C., Lo, C.K., Dong, T.T., and, Tsim, K.W. 2006. Gynecol. Endocrinol., 22: 578
2. Siddiqui, M.T., and, Siddiqi, M. 1976. Lipids, 11: 243
3. Wang, W., Tanaka, Y., Han, Z., and, Higuchi, C.M. 1995. Nutr. Cancer, 23: 131
4. Lauwaet, T., Andersen, Y., van de Ven, L., Eckmann, L., and, Gillin, F.D. 2010. J. Antimicrob. Chemother., 65: 531
5. Mu, H., Bai, Y.H., Wang, S.T., Zhu, Z.M., and, Zhang, Y.W. 2009. Phytomedicine, 16: 314
6. Wang, Q.Y., Meng, Q.H., Zhang, Z.T., Tian, Z.J., and, Liu, H. 2009. Acta Pharm. Sin., 44: 386
7. Zhang, S., Tang, X., Tian, J., Li, C., Zhang, G., Jiang, W., and, Zhang, Z. 2011. Basic Clin. Pharmacol. Toxicol., 108: 390
8. Huh, J.E., Kwon, N.H., Baek, Y.H., Lee, J.D., Choi, D.Y., Jingushi, S., Kim, K.I., and, Park, D.S. 2009. Int. Immunopharmacol., 9: 1357
9. Ha, H., Lee, H.Y., Lee, J.H., Jung, D., Choi, J., Song, K.Y., Jung, H.J., Choi, J.S., Chang, S.I., and, Kim, C. 2010. Arch. Pharm. Res., 33: 625
10. Huh, J.E., Nam, D.W., Baek, Y.H., Kang, J.W., Park, D.S., Choi, D.Y., and, Lee, J.D. 2011. Int. Immunopharmacol., 11: 46
11. Wu, J.H., Li, Q., Wu, M.Y., Guo, D.J., Chen, H.L., Chen, S.L., Seto, S.W., Au, A.L., Poon, C.C., Leung, G.P., Lee, S.M., Kwan, Y.W., and, Chan, S.W. 2010. J. Nutr. Biochem., 21: 613
12. Akiyama, H., Ishikawa, K., Kanamasa, K., Ogawa, I., Koka, H., Kamata, N., Nakai, S., and, Katori, R. 1997. Jpn Circ. J., 61: 503
13. Benzaquen, B.S., Cohen, V., and, Eisenberg, M.J. 2001. Am. Heart J., 142: 402
14. Donati, G., Pournaras, C.J., and, Tsacopoulos, M. 1998. Invest. Ophthalmol. Vis. Sci., 39: 1910
15. Morello, S., Vellecco, V., Alfieri, A., Mascolo, N., and, Cicala, C. 2006. Life Sci., 78: 825
16. Duarte, J., Jimenez, R., Villar, I.C., Perez-Vizcaino, F., Jimenez, J., and, Tamargo, J. 2001. Planta Med., 67: 567
17. Roghani, M., Baluchnejadmojarad, T., Vaez-Mahdavi, M.R., and, Roghani-Dehkordi, F. 2004. Vasc. Pharmacol., 42: 31
18. Zhu, X.M., Fang, L.H., Li, Y.J., and, Du, G.H. 2007. Vasc. Pharmacol., 46: 160
19. Rubanyi, G.M. 1993. J. Cardiovasc. Pharmacol., 22 Suppl. 4 (S1)
20. Nelson, M.T., and, Quayle, J.M. 1995. Am. J. Physiol., 268: C799
21. Horowitz, A., Menice, C.B., Laporte, R., and, Morgan, K.G. 1996. Physiol. Rev., 76: 967
22. Adams, P.J., and, Snutch, T.P. 2007. Subcell. Biochem., 45: 215
23. Eckert, R.E., Karsten, A.J., Utz, J., and, Ziegler, M. 2000. Urol. Res., 28: 122
24. Tirapelli, C.R., Ambrosio, S.R., da, C.F.B., Coutinho, S.T., de Oliveira, D.C., and, de Oliveira, A.M. 2004. Eur. J. Pharmacol., 492: 233
25. Jiang, H.D., Cai, J., Xu, J.H., Zhou, X.M., and, Xia, Q. 2005. J. Ethnopharmacol., 101: 221